Evidence map›Paper›PMID 22065533›Full record

ArticleArchives of general psychiatry2011

Racial/ethnic variations in substance-related disorders among adolescents in the United States.

Li-Tzy Wu, George E Woody, Chongming Yang, Jeng-Jong Pan, Dan G Blazer

Open access · bronzeAbstract read
In one paragraph

Article in Archives of general psychiatry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed, 1 pooled it
24.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 1 synthesis or guideline pooled it, 207 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Li-Tzy WuDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA. litzy.wu@duke.edu
George E Woody
Chongming Yang
Jeng-Jong Pan
Dan G Blazer
Duke Medical Center · US

Funding

Delaware Valley Node of the Clinical Trials NetworkU10DA013043 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI WOODY, GEORGE EDWARD · 1999 to 2015
$25.8M
Treatment/Substance Use Disorders/HIV Risk ReductionK05DA017009 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI WOODY, GEORGE EDWARD · 2003 to 2012
$1.3M
MDMA and Other Hallucinogen Use: Onset and Abuse/DependenceR01DA019623 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2007 to 2013
$1.1M
Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN StudiesR33DA027503 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2010 to 2012
$1.1M
Epdemiology of Non-Medical Prescription Anagesic UseR01DA019901 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2007 to 2009
$416k
NIDA NIH HHS HHSN271200522071CNIDA NIH HHS K05 DA017009NIDA NIH HHS K05DA017009NIDA NIH HHS R01 DA019623NIDA NIH HHS R01DA019623NIDA NIH HHS R01 DA019901NIDA NIH HHS R01DA019901NIDA NIH HHS R33 DA027503NIDA NIH HHS R33DA027503NIDA NIH HHS U10 DA013043NIDA NIH HHS U10DA013043
6 · The paper itself

Abstract

contextWhile young racial/ethnic groups are the fastest growing population in the United States, data about substance-related disorders among adolescents of various racial/ethnic backgrounds are lacking.

objectiveTo examine the magnitude of past-year DSM-IV substance-related disorders (alcohol, marijuana, cocaine, inhalants, hallucinogens, heroin, analgesic opioids, stimulants, sedatives, and tranquilizers) among adolescents of white, Hispanic, African American, Native American, Asian or Pacific Islander, and multiple race/ethnicity.

designThe 2005 to 2008 National Survey on Drug Use and Health.

settingAcademic research.

participantsNoninstitutionalized household adolescents aged 12 to 17 years.

main outcome measuresSubstance-related disorders were assessed by standardized survey questions administered using the audio computer-assisted self-interviewing method.

resultsOf 72 561 adolescents aged 12 to 17 years, 37.0% used alcohol or drugs in the past year; 7.9% met criteria for a substance-related disorder, with Native Americans having the highest prevalence of use (47.5%) and disorder (15.0%). Analgesic opioids were the second most commonly used illegal drugs, following marijuana, in all racial/ethnic groups; analgesic opioid use was comparatively prevalent among adolescents of Native American (9.7%) and multiple race/ethnicity (8.8%). Among 27 705 past-year alcohol or drug users, Native Americans (31.5%), adolescents of multiple race/ethnicity (25.2%), adolescents of white race/ethnicity (22.9%), and Hispanics (21.0%) had the highest rates of substance-related disorders. Adolescents used marijuana more frequently than alcohol or other drugs, and 25.9% of marijuana users met criteria for marijuana abuse or dependence. After controlling for adolescents' age, socioeconomic variables, population density of residence, self-rated health, and survey year, adjusted analyses of adolescent substance users indicated elevated odds of substance-related disorders among Native Americans, adolescents of multiple race/ethnicity, adolescents of white race/ethnicity, and Hispanics compared with African Americans; African Americans did not differ from Asians or Pacific Islanders.

conclusionsSubstance use is widespread among adolescents of Native American, white, Hispanic, and multiple race/ethnicity. These groups also are disproportionately affected by substance-related disorders.

Indexed as

AdolescentChildDemographyDiagnosis, Computer-AssistedDiagnostic and Statistical Manual of Mental DisordersFemaleHumansInterview, PsychologicalMalePopulation GroupsPrevalenceSelf ReportSocioeconomic FactorsSubstance-Related DisordersUnited States

Identifiers

PMID22065533
PMCPMC3395319
OpenAlexW2105640642

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.